DRKS00012877尚未招募2 期
Comparison of Response and Acute Toxicities of Concurrent Chemoradiation with Weekly Cisplatin Vs. Paclitaxel/Carboplatin in Locally Advanced Squamous Cell Carcinoma of Head & Neck: A Short-term Phase III Clinical Trial. - Shuayb HN CCRT Trial
Dr. Md Shuayb, MBBS, MSc, FCPS, Specialist, Oncology & Radiotherapy Centre, Square Hospitals Ltd.0 个研究点目标入组 100 人开始时间: 2017年8月16日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •1) SCCHN proved by histopathology.
- •2) AJCC stage-III, IVA and IVB.
- •3) Age: 18 to 75.
- •4) Eastern Cooperative Oncology Group (ECOG) performance status = 2.
- •5) Biochemical tests values: WBC= 3.5×10^9/L, Neutrophils =1.5×10^9/L, Platelets =100×10^9/L, haemoglobin =9gm/dl, Aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin =1.5×the upper limit of the institutional normal range, Creatinine concentration=120 umol/L, and creatinine clearance =50 ml/min.
- •6) No serious diseases of important organs.
- •7) Written informed consent signed prior to enrollment.
排除标准
- •1) Prior chemotherapy or head & neck irradiation,
- •2) Pregnant or lactating woman,
- •3) Serious diseases (include significant cardiovascular disease or uncontrolled diabetes) of important organs,
- •4) Other malignancies,
- •5) Active uncontrolled infection,
- •6) Joined in other clinical trial,
- •7) Stage IVB with cricoid cartilage invasion.
研究者
相似试验
尚未招募
Unknown
Acute reactions and dosimetry associated with old and new adjuvant radiation in carcinoma breastCTRI/2024/07/071736Dr.Harikrishna Suresh
尚未招募
不适用
Chemoradiotherapy Vs chemoradiotherapy with intraluminal brachytherapy is compared for treatment of ca esophagusCTRI/2019/01/016826IGMC Shimla
招募中
2 期
A STUDY COMPARING ACUTE SIDE EFFECTS AND BREASTCOSMESIS IN EARLY STAGE BREAST CANCER PATIENTS RECEIVING SHORT COURSE RADIOTHERAPY VERSUS VERY SHORT COURSE RADIOTHERAPYCTRI/2023/06/053665I
进行中（未招募）
不适用
Phase I/II study: on the toxicity and effects of combining the p53 synthetic long peptides vaccine with either Imiquimod or Interferon-alfa to induce polarized p53-specific immunity in patients treated for colorectal cancer - p53-SLP vaccine in combination with Imiquimod or IFNaEUCTR2008-004611-35-NLeiden University Medical Center
尚未招募
2 期
High dose radiotherapy in the treatment of advanced carcinoma cervix -a prospective studyCTRI/2023/07/055597Dr Anjan Bera